Wire Stories

Ntuple Launches Korea Railroad Ticketing System in Google Maps

Smart Mobility-as-a-Service 'ga-G' partners with Google Maps Korail tickets can be purchased with ga-G on…

Alteogen Enters Into an Exclusive License Agreement With Intas to Develop and Commercialize Two Products Enabled by Its Hybrozyme™ Technology

DAEJEON, South Korea--(BUSINESS WIRE)--#ALTB4--Alteogen Inc. (KOSDAQ:196170) announced today that it has entered into an exclusive…

The Portable, Personal Air Purifier – the LUFT Duo – Launches Worldwide at CES 2021

Keep the air free from pollutants and air-borne nasties wherever you are with the LUFT…

LG Chem to Contribute to Global Polio Eradication with Eupolio™, the First Sabin Inactivated Polio Vaccine to Receive WHO Prequalification

SEOUL, South Korea--(BUSINESS WIRE)--#Eupolio--LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received…

Kopin Corporation Enters Agreement with Jade Bird Display for 2K x 2K Monochrome LED Microdisplay Development

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of high-resolution microdisplays and…

Renesas and Sequans Expand Their 5G Collaboration

Broadband IoT Module for 5G NR FR1/FR2 in the Works TOKYO & PARIS--(BUSINESS WIRE)--#3GPP--Renesas Electronics…

Renesas Unveils Industry’s First 60W Wireless Power Receiver IC

Single-Chip P9418 IC Combines WattShare Technology, Best Thermal Performance, and Best-in-Class Current Sense Accuracy in…

Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership

SEOUL, South Korea--(BUSINESS WIRE)--#AI--Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company and SK…

Heritage Cannabis Places First Order with IntelGenx for CBD Filmstrips in Canada and Australia

TORONTO--(BUSINESS WIRE)--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced…

PharmaEssentia Initiates Pivotal Trial of Ropeginterferon alfa-2b to Treat Essential Thrombocythemia

With a diversifying pipeline, the company is evaluating applications for pegylated interferon to address underserved…